Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management

Core Insights - Silo Pharma has initiated a strategic agreement with Fireblocks to enhance its crypto treasury management platform, leveraging Fireblocks' expertise in secure digital asset custody and management [1][2]. Company Overview - Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved medical conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [3]. - The company's therapeutic portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis [3]. Partnership Details - Fireblocks is recognized as a leader in the digital assets space, having facilitated the secure transfer of over $10 trillion to date, and offers a multi-layer security framework that includes multi-party computation technology and a deposit address authentication network [2]. - The collaboration aims to build an institutional-grade infrastructure that enables Silo to buy, stake, and manage digital assets at scale [2].